a ctdna assay for remote monitoring and risk stratification of crc patients
Published 3 years ago • 93 plays • Length 35:05Download video MP4
Download video MP3
Similar videos
-
49:45
a ctdna assay for remote monitoring and risk stratification
-
18:43
advances in testing: a personalized, ctdna assay for mrd detection and surveillance
-
49:25
incorporating a personalized, tumor-informed ctdna monitoring assay in clinical practice
-
2:22
signatera for immunotherapy response monitoring
-
0:41
natera signatera product theater sabcs 2022: ctdna utility
-
2:19
introducing signatera, a personalized, tumor-informed test
-
0:40
how does signatera for immunotherapy response monitoring work?
-
3:12
peace of mind powered by signatera
-
8:18
the use of ctdna in patient cancer care
-
2:30
rsna 2019 - ct with advanced ai-assisted technologies
-
20:11
innovative options for noninvasive colorectal cancer screening
-
1:39
about signatera and ctdna
-
2:27
the signatera approach
-
3:04
first real-world ctdna analysis of oligometastic crc
-
9:00
adham jurdi, md | ctdna and mrd testing with the expanded access program
-
1:05:21
ctdna and mrd testing | colorectal cancer care tools for surveillance
-
3:25
monitoring patients with cancer using ctdna analysis
-
2:49
monitoring mrd by ctdna in resectable crc
-
0:38
introducing signatera, a personalized, tumor-informed test
-
7:53
ctdna mrd detection from plasma and urine in colorectal cancer
-
18:04
video: analysis of ctdna and cells with ultraseek on the massarray system (2017)
-
2:01
farshid dayyani, md | what is signatera?